Seeking Alpha

Stryker Biotech, a Stryker Corp. (SYK -0.9%) unit, pleaded guilty to misbranding a medical...

Stryker Biotech, a Stryker Corp. (SYK -0.9%) unit, pleaded guilty to misbranding a medical device during its trial over charges it marketed an unapproved mixture of products for strengthening human bone growth. The guilty plea means Stryker Corp. CEO Stephen MacMillan won't have to testify. Stryker will also pay a $15M fine. (submitted by Holly Thompson)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|